Download original image
Fig. 3.
Summary of the primary endpoint (gastrointestinal symptom [GIS] scores at baseline and week 4 in the per-protocol set population).
J Neurogastroenterol Motil 2021;27:87~96
https://doi.org/10.5056/jnm20061
© J Neurogastroenterol Motil
